Abstract Body

Substantial body composition and anthropometric alterations have been reported after initiating combined antiretroviral therapy (cART) in people living with HIV. Although weight gain may occur when cART-naïve individuals are placed on integrase inhibitor-based cART (INSTI), the effect of chronic treatment of patients switched to INSTI-based cART is unknown. We characterized a cohort of chronically infected, virologically suppressed (VL < 50 copies/ml) older men (? 50 years old) living with HIV (MLWH) with prior exposure to non-INSTI based cART who were switched to INSTI-based cART, and compared their body composition parameters and pro-inflammatory/endocrine profiles to age-matched MLWH on integrase-inhibitor free (non-INSTI) regimens, and to age-matched HIV-seronegative men.

Dual energy x-ray absorptiometry was used to quantify body composition, and plasma proinflammatory/endocrine markers were measured in MLWH (N = 56). Body composition of MLWH was compared to a publicly-available dataset of 450 HIV-seronegative men of similar age distribution. We compared body composition and plasma proinflammatory/endocrine markers between MLWH receiving INSTI-based and non-INSTI cART and assessed the effect of duration of cART on body composition.

MLWH had a greater android/gynoid ratio than HIV-seronegative men (p < 0.001). INSTI usage in MLWH was associated with lower total visceral adipose tissue mass (VAT) (p < 0.01) and greater plasma concentration of insulin-like growth factor-1 (IGF-1) (p < 0.05) compared to non-INSTI. Greater duration of cART was associated with lower android-gynoid ratio and trunk to leg ratio (p < 0.01).

Surprisingly, cART-experienced MLWH who switched to INSTIs had lower total VAT mass and higher plasma IGF-1 concentration than MLWH receiving non-INSTI based cART. These findings suggest that the weight gain associated with INSTI may be most pronounced when initiated in untreated HIV infection and may be less clinically important in cART-experienced populations. Longer duration of infection and age both associated with both lower android/gynoid ratio and lower trunk to leg ratio suggesting that aging and duration of cART impact metabolic risk. Initiation of INSTIs do not appear to have a negative effect on body composition, inflammation, or endocrine function in cART-experienced MLWH.